GILEAD SCIENCES, INC. - 03 Nov 2025 SCHEDULE 13D/A Report for Arcus Biosciences, Inc. Common Stock, par value $0.0001 (RCUS)

Filing Manager: GILEAD SCIENCES, INC.
Reporting Manager: GILEAD SCIENCES, INC.
Security: Arcus Biosciences, Inc. Common Stock, par value $0.0001
Symbol: RCUS
Shares outstanding: 122,752,969 shares
Disclosed Ownership: 31,424,760 shares
Ownership: 25.6%
Form type: SCHEDULE 13D/A
Filing time: 05 Nov 2025, 17:19:42 UTC
Date of event: 03 Nov 2025
Previous filing: 15 Jul 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GILEAD SCIENCES, INC.	25.6%	31,424,760	31,424,760	0	/s/ Andrew D. Dickinson	Andrew D. Dickinson, Executive Vice President and Chief Financial Officer	0000882095